{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:49:36Z","timestamp":1793875776283,"version":"4.7.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7644","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/nature21428","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T05:17:11Z","timestamp":1486012631000},"page":"248-251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":863,"title":["Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination"],"prefix":"10.1038","volume":"543","author":[{"given":"Norbert","family":"Pardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca S.","family":"Pelc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina R.","family":"DeMaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Scearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendeline","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Greenhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinor","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Sung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Sempowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara L.","family":"Mui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying K.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Vanlandingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica M.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikrishnan","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Karik\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampa","family":"Santra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barney S.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore C.","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barton F.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"BFnature21428_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.cell.2016.09.020","volume":"167","author":"TC Pierson","year":"2016","unstructured":"Pierson, T. C. & Graham, B. S. Zika virus: immunity and vaccine development. Cell 167, 625\u2013631 (2016)","journal-title":"Cell"},{"key":"BFnature21428_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1586\/14760584.2015.973859","volume":"14","author":"D Weissman","year":"2015","unstructured":"Weissman, D. mRNA transcript therapy. Expert Rev. Vaccines 14, 265\u2013281 (2015)","journal-title":"Expert Rev. Vaccines"},{"key":"BFnature21428_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","volume":"13","author":"U Sahin","year":"2014","unstructured":"Sahin, U., Karik\u00f3, K. & T\u00fcreci, \u00d6. mRNA-based therapeutics\u2014developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759\u2013780 (2014)","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnature21428_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","volume":"46","author":"GW Dick","year":"1952","unstructured":"Dick, G. W., Kitchen, S. F. & Haddow, A. J. Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46, 509\u2013520 (1952)","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BFnature21428_CR5","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1586\/14760584.2015.1083430","volume":"14","author":"AS Beck","year":"2015","unstructured":"Beck, A. S. & Barrett, A. D. Current status and future prospects of yellow fever vaccines. Expert Rev. Vaccines 14, 1479\u20131492 (2015)","journal-title":"Expert Rev. Vaccines"},{"key":"BFnature21428_CR6","doi-asserted-by":"publisher","first-page":"13845","DOI":"10.1128\/JVI.02086-14","volume":"88","author":"J Jarmer","year":"2014","unstructured":"Jarmer, J. et al. Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination. J. Virol. 88, 13845\u201313857 (2014)","journal-title":"J. Virol."},{"key":"BFnature21428_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","volume":"14","author":"B Guy","year":"2016","unstructured":"Guy, B. & Jackson, N. Dengue vaccine: hypotheses to understand CYD-TDV-induced protection. Nat. Rev. Microbiol. 14, 45\u201354 (2016)","journal-title":"Nat. Rev. Microbiol."},{"key":"BFnature21428_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ebiom.2016.09.028","volume":"13","author":"E Kim","year":"2016","unstructured":"Kim, E. et al. Preventative vaccines for Zika virus outbreak: preliminary evaluation. EBioMedicine 13, 315\u2013320 (2016)","journal-title":"EBioMedicine"},{"key":"BFnature21428_CR9","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1038\/npjvaccines.2016.21","volume":"1","author":"K Muthumani","year":"2016","unstructured":"Muthumani, K. et al. In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine. npj Vaccines 1, 16021 (2016)","journal-title":"npj Vaccines"},{"key":"BFnature21428_CR10","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aah6157","volume":"353","author":"P Abbink","year":"2016","unstructured":"Abbink, P. et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science 353, 1129\u20131132 (2016)","journal-title":"Science"},{"key":"BFnature21428_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","volume":"536","author":"RA Larocca","year":"2016","unstructured":"Larocca, R. A. et al. Vaccine protection against Zika virus from Brazil. Nature 536, 474\u2013478 (2016)","journal-title":"Nature"},{"key":"BFnature21428_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.aai9137","volume":"354","author":"KA Dowd","year":"2016","unstructured":"Dowd, K. A. et al. Rapid development of a DNA vaccine for Zika virus. Science 354, 237\u2013240 (2016)","journal-title":"Science"},{"key":"BFnature21428_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.vaccine.2010.10.037","volume":"29","author":"JE Ledgerwood","year":"2010","unstructured":"Ledgerwood, J. E. et al. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine 29, 304\u2013313 (2010)","journal-title":"Vaccine"},{"key":"BFnature21428_CR14","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1128\/JVI.78.6.2666-2673.2004","volume":"78","author":"SM Sumida","year":"2004","unstructured":"Sumida, S. M. et al. Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors. J. Virol. 78, 2666\u20132673 (2004)","journal-title":"J. Virol."},{"key":"BFnature21428_CR15","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1128\/JVI.02950-14","volume":"89","author":"P Abbink","year":"2015","unstructured":"Abbink, P. et al. Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors. J. Virol. 89, 1512\u20131522 (2015)","journal-title":"J. Virol."},{"key":"BFnature21428_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","volume":"479\u2013480","author":"PD Minor","year":"2015","unstructured":"Minor, P. D. Live attenuated vaccines: historical successes and current challenges. Virology 479\u2013480, 379\u2013392 (2015)","journal-title":"Virology"},{"key":"BFnature21428_CR17","doi-asserted-by":"publisher","first-page":"e00500","DOI":"10.1128\/genomeA.00500-14","volume":"2","author":"C Baronti","year":"2014","unstructured":"Baronti, C. et al. Complete coding sequence of zika virus from a French Polynesia outbreak in 2013. Genome Announc. 2, e00500\u201314 (2014)","journal-title":"Genome Announc."},{"key":"BFnature21428_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2015.08.051","volume":"217","author":"O Andries","year":"2015","unstructured":"Andries, O. et al. N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J. Control. Release 217, 337\u2013344 (2015)","journal-title":"J. Control. Release"},{"key":"BFnature21428_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","volume":"217","author":"N Pardi","year":"2015","unstructured":"Pardi, N. et al. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J. Control. Release 217, 345\u2013351 (2015)","journal-title":"J. Control. Release"},{"key":"BFnature21428_CR20","doi-asserted-by":"publisher","first-page":"e8325","DOI":"10.1371\/journal.pone.0008325","volume":"4","author":"PG Wang","year":"2009","unstructured":"Wang, P. G. et al. Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins. PLoS One 4, e8325 (2009)","journal-title":"PLoS One"},{"key":"BFnature21428_CR21","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.4049\/jimmunol.165.8.4710","volume":"165","author":"D Weissman","year":"2000","unstructured":"Weissman, D. et al. HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J. Immunol. 165, 4710\u20134717 (2000)","journal-title":"J. Immunol."},{"key":"BFnature21428_CR22","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.1038\/ncomms12204","volume":"7","author":"DM Dudley","year":"2016","unstructured":"Dudley, D. M. et al. A rhesus macaque model of Asian-lineage Zika virus infection. Nat. Commun. 7, 12204 (2016)","journal-title":"Nat. Commun."},{"key":"BFnature21428_CR23","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.celrep.2016.07.049","volume":"16","author":"KA Dowd","year":"2016","unstructured":"Dowd, K. A. et al. Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype. Cell Reports 16, 1485\u20131491 (2016)","journal-title":"Cell Reports"},{"key":"BFnature21428_CR24","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","volume":"19","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. et al. A mouse model of Zika virus pathogenesis. Cell Host Microbe 19, 720\u2013730 (2016)","journal-title":"Cell Host Microbe"},{"key":"BFnature21428_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-62703-260-5_2","volume":"969","author":"N Pardi","year":"2013","unstructured":"Pardi, N., Muramatsu, H., Weissman, D. & Karik\u00f3, K. In vitro transcription of long RNA containing modified nucleosides. Methods Mol. Biol. 969, 29\u201342 (2013)","journal-title":"Methods Mol. Biol."},{"key":"BFnature21428_CR26","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/mt.2015.103","volume":"23","author":"A Thess","year":"2015","unstructured":"Thess, A. et al. Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals. Mol. Ther. 23, 1456\u20131464 (2015)","journal-title":"Mol. Ther."},{"key":"BFnature21428_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-62703-260-5_3","volume":"969","author":"D Weissman","year":"2013","unstructured":"Weissman, D., Pardi, N., Muramatsu, H. & Karik\u00f3, K. HPLC purification of in vitro transcribed long RNA. Methods Mol. Biol. 969, 43\u201354 (2013)","journal-title":"Methods Mol. Biol."},{"key":"BFnature21428_CR28","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Karik\u00f3","year":"2008","unstructured":"Karik\u00f3, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833\u20131840 (2008)","journal-title":"Mol. Ther."},{"key":"BFnature21428_CR29","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/mt.2013.124","volume":"21","author":"MA Maier","year":"2013","unstructured":"Maier, M. A. et al. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol. Ther. 21, 1570\u20131578 (2013)","journal-title":"Mol. Ther."},{"key":"BFnature21428_CR30","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.1002\/anie.201203263","volume":"51","author":"M Jayaraman","year":"2012","unstructured":"Jayaraman, M. et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo . Angew. Chem. Int. Edn Engl. 51, 8529\u20138533 (2012)","journal-title":"Angew. Chem. Int. Edn Engl."},{"key":"BFnature21428_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","volume":"346","author":"TC Pierson","year":"2006","unstructured":"Pierson, T. C. et al. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346, 53\u201365 (2006)","journal-title":"Virology"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature21428.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature21428","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature21428.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:00:03Z","timestamp":1684418403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature21428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":31,"journal-issue":{"issue":"7644","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFnature21428"],"URL":"https:\/\/doi.org\/10.1038\/nature21428","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727261558.793535162","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.727261558.793533376","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]},"assertion":[{"value":"14 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.P., M.J.Hog., K.K. and D.W. are named on patents that describe the use of nucleoside-modified mRNA as a platform to deliver therapeutic proteins and vaccines. We have disclosed those interests fully to the University of Pennsylvania, and have an approved plan in place for managing any potential conflicts arising from licensing of our patents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}